INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 211 filers reported holding INSMED INC in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $230,000 | 0.0% | 9,801 | +15.7% | 0.07% | +11.5% |
| Q4 2021 | $230,000 | -3.0% | 8,470 | -2.0% | 0.06% | +17.3% |
| Q3 2021 | $237,000 | -4.4% | 8,641 | -0.8% | 0.05% | +10.6% |
| Q2 2021 | $248,000 | -19.0% | 8,707 | -3.1% | 0.05% | -21.7% |
| Q1 2021 | $306,000 | +24.4% | 8,988 | +21.9% | 0.06% | +36.4% |
| Q4 2020 | $246,000 | -14.9% | 7,375 | -18.1% | 0.04% | -25.4% |
| Q3 2020 | $289,000 | +11.2% | 9,003 | -4.8% | 0.06% | +3.5% |
| Q2 2020 | $260,000 | +24.4% | 9,454 | +8.1% | 0.06% | +35.7% |
| Q4 2019 | $209,000 | – | 8,746 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 250,584 | $4,420,000 | 9.48% |
| Palo Alto Investors LP | 7,239,649 | $127,707,000 | 8.51% |
| Foresite Capital Management IV, LLC | 1,429,518 | $25,217,000 | 8.15% |
| First Light Asset Management, LLC | 1,294,743 | $22,839,000 | 3.45% |
| Foresite Capital Management II, LLC | 915,016 | $16,141,000 | 3.41% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 356,600 | $6,287,000 | 2.90% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $3,881,000 | 2.80% |
| EMERALD ADVISERS, LLC | 984,987 | $17,375,000 | 0.81% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 911,936 | $16,087,000 | 0.71% |
| Rock Springs Capital Management LP | 890,000 | $15,700,000 | 0.63% |